Abstract. The selenoprotein phospholipid hydroperoxide glutathione peroxidase (PHGPx) is highly expressed in testes under gonadotropin control. The expression patterns of PHGPx mRNA by 17β-estradiol (E2) as an estrogen and tamoxifen (Tam) as an estrogen antagonist were investigated in the reproductive organs of male rats. Twelve-week-old male Sprague-Dawley rats were subcutaneously injected with E2 (7.5 µg/kg/day) or Tam (5 mg/kg/day) for 1 week. The E2 treatment significantly increased the levels of PHGPx mRNA in both testes and prostates, whereas the Tam treatment significantly decreased the levels of PHGPx mRNA, compared to the vehicle control (p<0.01). The treatment with E2 or Tam slightly decreased the levels of PHGPx mRNA in epididymides. In histopathological examination, severe vacuolization and depletion of germ cells in the seminiferous tubules, cell debris in the tubular lumen, and mild proliferative changes in interstitial tissues were observed in the testes of Tam-treated rats, whereas only mild spermatogonial proliferation was observed in the seminiferous tubules of E2-treated rats. There were no typical histopathological changes in the epididymides of any of the laboratory rats but mild epithelial proliferation in the prostates of E2-and Tam-treated rats. These results suggest that PHGPx mRNA expression may be influenced by estrogen in the male reproductive organs.
of rats, followed by the kidney, heart and skeletal muscles, liver, brain, lung, and spleen [9] . PHGPx is localized in the intermembrane space, possibly at the contact sites of the two membranes in testis mitochondria [10] . PHGPx activity is influenced by the testosterone level during spermatogenesis [11] . In testis, PHGPx is preferentially expressed after puberty, whereas it remains essentially absent after hypophysectomy; it could be partially restored in h yp o ph ys e c t o m iz ed r a t s by g o n ad o t r o pi n treatment, and immunohistochemical studies indicated an association of PHGPx with the s em i n i f e r ou s e p i t h el i u m . P H G P x m R N A expression increases up to the stage of round spermatids and decreases at the stage of elongate forms [12] . Furthermore, it completely disappears in spermatozoa [13] . Therefore, PHGPx mRNA expression depends on sexual maturation [11] .
It is widely accepted that estrogen is a typical female hormone. In the male, an exposure to estrogen compounds can lead to reduction in gonad size, feminization of genetic males, a low s p e r m c o u n t a n d / o r m ot i l i t y [ 1 4 , 1 5 ] . Nevertheless, it has been reported that estrogen is present in some male vertebrates [16, 17] and that it is normally expressed in the male reproductive organs [18] . In mammals, estrogen appears to regulate the reabsorption of luminal fluid in epididymides [19] and to affect sexual behavior [20] . 17β-estradiol (E2), an intrinsic estrogen in vertebrates, is present in the serum and its receptor is expressed in the testis during the whole process of spermatogenesis [21] . Even though there has been a noticeable increase in reports analyzing the actions of estrogen in the testis, the functions of estrogen in male reproduction have not been clearly established.
Bringers-Folhe et al. (1994) reported that pig PHGPx has several estrogen responsive elements in its genomic site [22] . This suggests that estrogen might be associated with the transcription of PHGPx, but no direct evidence of PHGPx levels related to estrogen has yet been established. In this study, PHGPx mRNA levels in male reproductive organs of rats treated with E2 as an estrogen or tamoxifen (Tam) as an estrogen receptor antagonist were investigated by means of Northern blotting, reverse transcription-polymerase chain reaction (RT-PCR), and histopathological analyses.
Materials and Methods

Chemicals:
17β 
Laboratory animals
Eleven-week-old male Sprague-Dawley rats (300-350 g) were purchased from a commercial breeder (Daehan Laboratory Animal Center, Seoul, K o r e a ) a n d a c c l i m a t e d t o t h e l a b or a t o r y environment for 1 week before this study. Fifteen rats were divided into three experimental groups (5 animals per group) including E2 (7.5 µg/kg/day), Tam (5 mg/kg/day), and vehicle corn oil control groups. The test chemicals were subcutaneously injected into the animals for 1 week. They were housed in a polycarbonate cage with a stainless steel cover and kept in a n environmentally controlled room with constant temperature (23 ± 3 C), relative humidity (50 ± 10%), and a 12-h light cycle. The rats were fed a standard commercial diet (Samyang Co., Seoul, Korea) and tap water ad libitum. All animal experiments were conducted in compliance with "Guide for care and use of laboratory animals" of the National Institutes of Health in the U.S.A. All animals were killed under light ether anesthesia. Reproductive organs removed were kept at -70 C for RNA extraction.
Total RNA extraction and first strand cDNA synthesis Total RNAs were isolated from the testes, epididymides, and prostates with TRIzol Reagent (Gibco BRL; Grand island, NY, USA) according to the manufacturer's manual. The quantity and quality of the total RNAs isolated were determined by spectrophotometry at 260 nm and by ultraviolet light visualization of an ethidium bromide-stained agarose formalin gel. The total RNAs were kept at -70 C until use. First strand cDNA was synthesized with a Superscript Preamplication System (Gibco). Total RNA (5 µg), oligo(dT)12-28 primer, and dNTPs were mixed in a PCR tube and incubated at 70 C for 10 min. After incubation, the tube was placed on ice for at least 1 min, and then into it was added 9 µl a mixture of 2 µl of 10-strength RT butter, 4 µl of 25 mM MgCl2, 2 µl of 0.1 mM DTT and 1 µl of RNase inhibitor. The PCR tube was kept at 42 C for 2 min and then 1 µl of reverse transcriptase was added. After mixing, the tube was incubated at 42 C for 50 min. Termination of the reaction was performed at 70 C for 15 min. To remove the RNA/DNA hybrid, 1 µl of RNase H was added and incubated at 37 C for 20 min. The products were kept at -20 C until use.
PCR analysis
To determine the expression pattern of PHGPx mRNA in epididymis and prostate, 1 µl of cDNA was amplified in a thermal cycler (MJ Research; Waltham, MA ,USA) with the primers [S1 and AS2 fragment (461 bp); Nam et al. [23] . The PCR mixture was made as follows: 0.15 µl of TaqGold DNA polymerase (Perkin Elmer; Foster City, CA, USA), 2.5 µl of dNTPs, 2.5 µl of 10-strength PCR buffer containing 1.5 mM MgCl2, 1 µl each of sense and antisense primers, and 1 µl of template cDNA i n 1 6 . 8 5 µ l o f u l t r a -d i s t i l l e d w a t er . P C R amplification was carried out in the thermal cycler according to a protocol for the initial denaturing step at 95 C for 10 min; then 35 cycles at 95 C for 1 min (denaturing), at 55 C for 1 min (annealing), and at 72 C for 1.5 min (extension); and a further extention at 72 C for 10 min. The PCR products were run on a 2% agarose gel in Tris-borateethylene diaminetetraacetic acid disodium salt (EDTA) buffer. Beta-actin primers were used as an internal standard control [12] .
Northern blotting analysis
Testicular total RNAs (20 µg) in each group were fractionated on a 1% agarose formalin gel. The gel was stained with ethidium bromide to verify the even loading of RNA. After an electrophoresis, the lo adin g gel w as c om plet ely blo tt ed o nt o a hybridization transfer membrane (NEN Life Science Products; Boston, MA, USA) by a vacuum blotting system (Biometra; Gottingen, Germany) f o r 1 20 m i n. T h e t r an s f er m em b r an e w as prehybridized in hybridizat ion so lutio n (2 st rength-s tanda rd s aline citrate (S SC), 5 0% formamide, 10% SDS, 10% N-laurylsarcosine in diethylpyrocarbonate (DEPC)-treated water at 65 C for 30 min. Hybridization was then done at 65 C for 1 6 h w i t h a d e n at u r ed -d i g ox i g en i n (D I G ; Boehringer mannheim, Germany)-labeled cRNA probe for PHGPx. After hybridizat ion, the membrane was washed in 40 ml of 2 strength-SSC containing 0.1% SDS at room temperature for 30 min twice and in 0.5X SSC containing 0.1% SDS at 65 C for 30 min once thoroughly. The membrane was immersed in 2% DIG blocking solution with slow shaking and then incubated with an anti-DIG alkaline phosphatase-conjugated antibody (F. Hoffmann-La Roche Ltd; Basel, Switzerland) in PBS at room temperature for 60 min with slow shaking. CDP-star (Applied Biosystems; Foster City, CA, USA) was used for chemiluminescence detection and each signal was developed on an X-ray film (Kodak; Tokyo, Japan).
Histopathological examination
Ea ch tissue was fixed in Bouin's fixa tive, dehydrated through increasing concentrations of ethyl alcohol, cleared in xylene, infiltrated in paraffin and paraplast by means of an automatic tissue processor (Thermo Shandon Inc; Pittsburgh, PA, USA), and embedded in the paraffin wax with an embedding machine (Leica; Iteidelbenger, Germany). The tissue blocks were cut into 5 µm thicknesses on a rotary microtome (Leica), stained with hematoxylin and eosin (H & E), and observed under a light microscope (Leica).
Statistical analysis
Data were statistically evaluated by one-way ANOVA. For a significant difference between treatment groups and control group, the Student's t-test was performed at the level of P<0.05.
Results
Expression pattern of PHGPx mRNA
By Northern blotting analysis, the testicular PHGPx mRNA level in rats was illustrated (Fig. 1) . The treatment with E2 at a dose of 7.5 µg/kg/day significantly increased the PHGPx mRNA levels in testes by 50%, while the treatment with Tam at a dose of 5 mg/kg/day significantly decreased the PHGPx mRNA level by 53%, compared to the control (P<0.01). The total RNAs isolated from the epididymides and prostates were analyzed by the RT-PCR technique, since PHGPx mRNAs in both organs could not been detected by Northern blotting. In epididymides, the treatment with E2 or Tam slightly decreased the PHGPx mRNA levels, but those were not significantly different from that of the control (Fig. 2) . In prostate, the treatment with E2 greatly increased the PHGPx mRNA level by 55% (P<0.01), whereas the treatment with Tam noticeably decreased the PHGPx mRNA levels by 41% (P<0.01), compared to the control (Fig. 3) .
Histopathological findings
Severe degeneration and loss of germ cells, and moderate atrophy of the seminiferous tubules were observed in the testes treated with Tam (Fig. 4) . The lesions were characterized by a decrease in tubule size, disappearance of spermatocytes from the seminiferous tubules, vacuolization of the seminiferous epithelium, deletion of germinal epithelium, and mild hyperplasia of the interstitial cells. Nevertheless no lesions were observed in the testes of control and E2-treated rats. Instead, mild spermatogonial proliferation was observed in the seminiferous tubules of E2-treated rats (Fig. 4) . There were no typical histopathological changes in the epididymides (Fig. 5) . In prostates, mild proliferative changes in the epithelium were observed in E2-or Tam-treated rats (Fig. 6 ).
Discussion
In porcine PHGPx, the 5'-untranslated region and the first intron contain a variety of putative r e g u l a to r y e l e m e n ts i n c l u d i n g e s t r o g e n , progesterone and glucocorticoid-responsive elements [22] . The testicular PHGPx level in rats is kept close to zero by hypophysectomy, but is partially restored by gonadotropin treatment [13] . In the present study, the levels of PHGPx mRNA in the testes and prostates of rats were greatly influenced by treatment with E2 or Tam. These findings indicate that PHGPx transcription may be regulated by steroid hormones such as estrogens in male reproductive organs. E2, an intrinsic estrogen in vertebrates, is present in the sperm and its receptor is expressed in various germ cell types during spermatogenesis [21] . A long period exposure to estro gens leads to reduction in gonad size, feminization of genetic males, low sperm count and/or motility [14] . Nevertheless, treatment with E2 at a low dose promotes spermatogonial stem cell renewal, which has been suppressed by TAM, a competitive antagonist of estrogen receptor [21] , suggesting that a low level of estrogens may be necessary for norma l spermatogenesis. In this study, the treatment with E2 at a dose of 7.5 µg/kg/day for 1 w ee k r e su l t ed i n a sl ig h t pr ol if e r at i on of seminiferous epithelium, but daily treatment with E2 at the same dose for 5 weeks caused a severe loss and degeneration of germ cells in the seminiferous tubules in the current observation in our extended study. These findings indicate that estrogens may have a controversial effect on spermatogenesis according to the dosage and exposure duration.
There are two types of estrogen receptors (ERs), ERα and ERβ, which differ in the C-terminal ligand binding domain and N-terminal transactivation domain. The tissue distribution and the relative expression level of ERα and ERβ seem to be different in varying tissues. ERα is strongly expressed high in uterus, testis, pituitary, ovary, kidney, epididymis and the adrenal gland, whereas ERβ is strongly expressed in prostate, ovary, lung, urinary bladder, brain, uterus and testis [24] . On the other hand, Fugger et al. (2000) suggested that TAM acts as an ERβ antagonist [25] . Pettersson et al. (2000) also reported that ERβ functions as a dominant regulator of estrogen signaling [26] . In this study, the expression of PHGPx mRNA in the testis and prostate was greatly increased by E2 treatment, but it was remarkably decreased by TAM treatment. Nevertheless, the PHGPx mRNA levels in the epididymis were not significantly changed by E2 or TAM treatment compared to that of control. These results indicate that PHGPx gene expression may be mainly related to ERβ. Mo use PHGPx m RNA is expressed stagespecifically during spermatogenesis. The signal first appears in pachytene spermatocytes at Stage X and is mainly expressed in spermatids. PHGPx mRNA is also detected in interstitial Leydig cells [12] . van Pelt et al. [27] have shown that ERβ mRNA and activity were principally found in pachytene spermatocytes and round spermatids. A l o w E R β le ve l w as o b s er v ed i n all t y pe A spermatogonia, whereas no expression was found in early spermatocytes and interstitial cells, indicating that PHGPx and ERβ are directly involved in spermatogenesis. In this study, a mild spermatogonial proliferation was observed in seminiferous tubules of rats treated with E2, w h e r e a s a s e v e r e l o s s o f g e r m c e l l s a n d degeneration of seminiferous tubules were found in rats treated with Tam. During spermatogenesis, therefore, PHGPx activity may be inhibited by Tam, an endogenous estrogen blocker, but it may be stimulated by exogenous E2 treatment. From t hes e res ult s, we co nc lude t hat exo geno us estrogens increase PHGPx gene expression by forming a complex with ERβ, then binding to estrogen-responsive elements of the PHGPx gene with unknown coactivators, which regulate the expression of PHGPx. In contrast, Tam blocks the binding of estrogen with ERβ, thereby reducing the expression of PHGPx. To elucidate the correlation of PHGPx with ERβ, more detailed studies remain to be performed in the near future.
